on BASTIDE (EPA:BLC)
Groupe Bastide Sells New Medical Concept to Sapio Group
On May 21, 2026, Groupe Bastide announced the sale of its subsidiary, New Medical Concept, the holding company of the EXPERF group, to Sapio Group. EXPERF, specializing in home infusion and clinical nutrition care, has doubled its revenue since its acquisition in 2017, reaching €42 million in the 2024-2025 financial year.
This transaction aligns with Groupe Bastide's strategy of asset rotation and financial strengthening. The sale is expected to reduce financial expenses and improve the financial leverage ratio to above 2.5x post-transaction. However, it will not impact the company’s reported revenue for the current financial year.
Sapio Group's CEO, Mario Paterlini, noted that acquiring EXPERF is crucial for their growth in the European healthcare market. The deal awaits customary closing conditions.
R. P.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all BASTIDE news